Ravindra Dnyandev Jadhav

Title: Innovations by Ravindra Dnyandev Jadhav

Introduction

Ravindra Dnyandev Jadhav is a notable inventor based in Mumbai, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target diacylglycerol acyltransferase (DGAT). With a total of three patents to his name, Jadhav's work is focused on creating innovative solutions for medical treatments.

Latest Patents

Jadhav's latest patents include advancements in diacylglycerol acyltransferase inhibitors. The first patent relates to isoxazole, thiazole, and oxidiazole derivatives, which are designed for the prevention and treatment of diseases mediated by DGAT, specifically DGAT1. The second patent involves heterocyclic compounds in various forms, including their pharmaceutically acceptable salts and solvates. This invention also outlines processes for manufacturing these compounds and their use in pharmaceutical compositions aimed at treating disorders linked to DGAT.

Career Highlights

Ravindra Dnyandev Jadhav is currently associated with Piramal Enterprises Limited, where he continues to innovate in the pharmaceutical sector. His work has been instrumental in advancing the understanding and treatment of diseases related to diacylglycerol acyltransferase.

Collaborations

Some of Jadhav's notable coworkers include Rajiv Sharma and Kishorkumar Shivajirao Kadam. Their collaborative efforts contribute to the innovative environment at Piramal Enterprises Limited.

Conclusion

Ravindra Dnyandev Jadhav's contributions to pharmaceutical innovations highlight his commitment to improving medical treatments through his patented inventions. His work continues to pave the way for advancements in the field.